Obesity, albuminuria, and gamma-glutamyl transferase predict incidence of hypertension in indigenous Australians in rural and remote communities in northern Australia by Li, Ming & McDermott, Robyn
Original ArticleObesity, albuminuria, and gamma-glutamyl
transferase predict incidence of hypertension in
indigenous Australians in rural and remote
communities in northern AustraliaMing Lia and Robyn McDermotta,bJournal of Hypertension 2015, 33:704–710
aSchool of Population Health, Sansom Institute for Health Research, Public Health
Group, University of South Australia, Adelaide and bFaculty of Medicine, Health &
Molecular Sciences, James Cook University, Cairns, Queensland, Australia
Correspondence to Ming Li, School of Population Health, Sansom Institute for Health
Research, University of South Australia, IPC CWE-48, GPO Box 2471, Adelaide SA
5001, Australia. Tel: +61 8 8302 1051; fax: +61 8 8302 2794; e-mail: Ming.Li@
unisa.edu.au
Received 13 June 2014 Revised 27 October 2014 Accepted 27 October 2014
J Hypertens 33:704–710 Copyright  2015 Wolters Kluwer Health, Inc. All rights
reserved. This is an open-access article distributed under the terms of the
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License, where
it is permissible to download and share the work provided it is properly cited. The
work cannot be changed in any way or used commercially.Objective: To describe the incidence of hypertension in a
cohort of Australian Aboriginal and Torres Strait Islanders.
Method: A follow-up study conducted among 1831
indigenous population aged 15 years and over without
hypertension at baseline from 19 communities in North
Queensland during 1997–2008. Main measurements
included baseline and follow-up weight, waist
circumference, blood pressure, fasting glucose, lipids
(triglycerides and cholesterol), gamma-glutamyl transferase,
urinary albumin creatinine ratio, self-reported tobacco
smoking, alcohol intake and physical activity.
Results: Hundred cases of hypertension developed over
2633.4 person-years giving a crude incidence of
hypertension of 22.6 (16.2–31.4) per 1000 person-years in
females and 60.0 (47.1–76.6) per 1000 person-years for
males. Age standardized overall incidence was 51.9 per
1000 person-years. Aboriginal participants were twice as
likely as Torres Strait Islanders to develop hypertension,
which increased with age. Obesity (BMI >30) strongly
predicted incident hypertension independently of age or
sex (adjusted hazard ratio 2.9, 95% confidence interval
1.9–4.8). Albuminuria and elevated gamma-glutamyl
transferase increased the risk of hypertension (adjusted
hazard ratio 1.4–1.7) in this population.
Conclusion: Incidence of hypertension in indigenous
Australian adults is nearly double than that of the general
Australian population. High background prevalence of
obesity, diabetes and albuminuria contributes to this
excess. As well as early detection and management of
high blood pressure, albuminuria and diabetes in
primary care settings, attention should be equally focused
on community-level prevention and management of
obesity.
Keywords: albuminuria, Australian indigenous population,
gamma-glutamyl transferase, incidence of hypertension,
overweight and obesity
Abbreviations: AusDiab, The Australian Diabetes, Obesity
and Lifestyle Study; BP, blood pressure; GGT, gamma-
glutamyl transferase; TSIs, Torres Strait Islanders; UACR,
urinary albumin creatinine ratio704 www.jhypertension.comINTRODUCTIONH
igh blood pressure (BP) is a major risk factor for
death, stroke, and renal and coronary heart dis-
ease. The estimated global prevalence of hyper-
tension in 2000 was 26% of adults, and by 2025, it was
estimated that this would rise by 24% in developed
countries and 80% in developing countries [1]. In Australia,
high BP is the most common of all the conditions of the
circulatory system. In 2011–2012, it was estimated that 32%
Australians aged 18 years and over had high BP (SBP or
DBP was 140/90mmHg or taking medication). Of these,
more than two-thirds (68%) had uncontrolled or unman-
aged high BP [2]. High BPwas the greatest contributor to the
burden of cardiovascular disease (CVD), accounting for
42.1% of CVD’s total burden in Australian population as
reported in 2003 [3]. Most of the studies reporting hyper-
tension incidence and its risk predictors are from the United
States [4]. Demographic, anthropometric and dietary factors
have been associated with hypertension [4]. Diabetes or
fasting insulin concentrations also predict hypertension
incidence [5,6]. The Australian indigenous population has
higher prevalence of risk factors including poor diet, smok-
ing and features of the metabolic syndrome [7]. A survey of
central Australian Aboriginal adults in the 1990s found that
the prevalence of hypertension was three times higher than
in non-indigenous Australians, and was associated with
overweight, higher albumin creatinine ratio (ACR) and
diabetes [8]. The incidence of hypertension in Australian
population, especially among indigenous populations, hasDOI:10.1097/HJH.0000000000000462
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Obesity predicts hypertension in indigenous Australiansnot been reported to date. We have previously found that
overweight and obesity predict diabetes incidence [9],
whereas hyperglycaemia or diabetes and hypertension,
in turn, predict coronary heart disease and act conjointly
with albuminuria [10]. This study aimed to document hy-




Baseline data were collected from 2152 adults in 19 rural
indigenous communities across three health districts in far
North Queensland, who participated in the ‘Well Person’s
Health Check’ between 1999 and 2000. Methods for this
cross-sectional study have been reported in detail else-
where [11]. Briefly, all indigenous residents of the com-
munities aged 13 years and over were invited to attend a
health check through printed media, local radio and word
of mouth via local health services, community councils and
community groups. On the basis of the local census data,
the study achieved a participation rate of 44.5%, with
greater participation noted in smaller communities. The
follow-up data were collected during 2005–2007. On the
basis of the census data, participants overall were not
different demographically from the age and sex distribution
of the Australian indigenous population as a whole. The
study protocols were approved by the Cairns Base Hospital
Human Research Ethics Committee with support from the
peak Indigenous Health Organizations, Apunipima Cape
York Health Council, and the Torres Strait and Northern
Peninsula Area Health Council.
Measurements
Participants were asked to remove foot wear and heavy
clothing, and weighed to the nearest 0.1 kg. Height and
waist circumference were recorded to the nearest centi-
metre, with the latter measured by the same technician at
the level of the umbilicus. BMI was calculated as weight
(kg) divided by the height squared (m2). Fruit and veg-
etable intake, and alcohol consumption were assessed
using a methodology derived from that used in the National
Nutrition Survey 1995 [12], and categorized using Australian
dietary guideline [13]. Physical activity was measured using
a 7-day recall method in which participants were asked to
report daily physical activities of at least 30min duration
and moderate intensity performed during the week before
their health check. Physical activity was categorized using
the WHO criteria in which ‘enough’ means doing moderate
to vigorous physical activity for more than 30min/day for 5
days in the week before the survey [14]. Current smokers
were asked how many cigarettes they smoked daily. The
self-reported physical activity, smoking and alcohol intake
measures are widely used in other studies [15,16].
Gamma-glutamyl transferase (GGT), fasting total choles-
terol, high-density lipoprotein cholesterol (HDLC), trigly-
cerides and glucose were measured on blood collected in
the early morning after at least an 8 h fast by a medical
officer, registered nurse or trained phlebotomist, as
described in detail elsewhere [11]. GGT was measured
using the kinetic photometric procedure with Cobas IntegraJournal of Hypertension800 (Roche Diagnostics, New York, USA). Blood glucose
and blood lipids were measured using photometric enzyme
endpoint assay with Cobas Integra 700/400 (Roche Diag-
nostics).
Blood pressure was the average of three measurements
taken sitting after 10min rest. Participants were seated
comfortably with their arms outstretched and supported
at chest height. An inflatable cuff appropriate to the partici-
pants’ arm size was applied just above the elbow centred
over the radial artery. BP was measured using a Dinamap
model 800 automated blood pressure monitor (Critikon;
Tampa, Florida, USA). Three separate measurements were
recorded over approximately a 10-min period. Baseline
hypertension was ascertained either by detection of high
BP at examination (measured BP> 140/90mmHg) or
previous confirmed diagnosis or currently prescribed anti-
hypertensive medication (by medical record review) [11].
Urine specimens provided by participants in sterile 50-ml
containers were from the first morning void or a sample at
least 2 h from the most recent void. Dipstick urinalysis
(Combur-test, Roche) tested the samples for protein, pH,
nitrites, leucocytes and blood. ACR was measured by
immunoassay in g/mol.
Diabetes was defined as either clinical diagnosis verified
by the participants’ medical records or a 2-h glucose toler-
ance test, or fasting blood glucose level at least 7.0mmol/l
[17]. Overweight was defined as BMI 25–30 kg/m2 and
obese as BMI above 30 kg/m2 using the WHO criteria
[14]. Abdominal overweight was defined as waist circum-
ference greater than 80 cm in females and 94 cm in males,
and obesity as greater than 88 cm in females and 102 cm in
males [13]. Dyslipidaemia was defined as having triglycer-
ides at least 2.0mmol/l or HDLC below 1.0mmol/l, as
recommended by the National Heart Foundation [18].
Analysis
This analysis excluded participants who were identified as
non-indigenous, who were aged less than 15 years or who
had hypertension at baseline.
Incident hypertension was defined as the first study visit,
subsequent to baseline, at which the participant had SBP at
least 140mmHg, or DBP at least 90mmHg, or had initiated
treatment with antihypertensive medications. The follow-
up period for incident hypertension cases was the time from
entering the baseline study to diagnosis date. For those who
did not develop hypertension, the follow-up period was the
interval between the day of baseline survey and the follow-
up. The age–sex-specific cumulative incidence rate strati-
fied by ethnicity was calculated by dividing the number of
new cases by the total person follow-up years of the
corresponding subgroups. Direct standardization was con-
ducted using the 2007 Australian Bureau of Statistics
national data as the reference population.
Baseline characteristics including age, sex and ethnicity,
self-reported health behaviours including tobacco smok-
ing, alcohol and fruit and vegetable intake, blood pressure,
fasting glucose, blood lipids, urinary ACR (UACR) and GGT
levels were compared between incident hypertension cases
and non-hypertension cases using log-rank tests. The Cox
proportional-hazard model was used to identify the signifi-
cant baseline factors associated with incident hypertension.www.jhypertension.com 705
Li and McDermottThe reported crude hazard ratios show the results of a
univariate Cox model. The association for each ethnic
group was adjusted for age, sex and further adjusted for
ethnicity in the combined hazard ratio estimate. The
analysis was carried out using STATA 12 (STATAcorp,
College Station, Texas, USA) and significance level was
set at two-sided P value less than 0.05.
RESULTS
A total of 1831 indigenous population aged 15 years and
over without hypertension at baseline from 19 communities
in North Queensland during 1997–2008 was included in the
analysis. Among them, 401 completed the second survey.
Of those lost to follow-up, 83 were dead, 22 were in prison,
344 had moved out of the community and 981 did not
attend the follow-up survey. Those lost to follow-up were
similar in all baseline characteristics except for a slight
excess of younger aboriginal males with a more favourable
lipid profile and lower alcohol intake. The baseline charac-
teristics of the 401 participants completing the follow-up
were shown in Table 1. Among them, 59% were females,
with a mean age of 31.4 years (range 15–78 years). There
were 149 aboriginal people (37%) and 190 (47%) Torres
Strait Islanders (TSIs). Only 2% met the recommended dailyTABLE 1. Baseline characteristics of participants completing follow-u
Aboriginal TSI
Female n¼87 n¼11
Age (years) 33.4 (30.5–36.2) 32.0 (30.0–3
WC (cm) 91.2 (87.5–94.9) 101.5 (98.4–1
BMI (kg/m2) 25.5 (24.0–27.1) 31.4 (30.0–3
SBP (mmHg) 114.1 (111.6–116.6) 117.9 (116.0–
DBP (mmHg) 64.0 (62.0–66.0) 62.9 (61.2–6
Fasting glucose (g/l) 5.1 (4.7–5.5) 5.4 (5.0–5.7
Cholesterol (mmol/l) 4.6 (4.3–4.8) 4.8 (4.6–4.9
HDLC (mmol/l) 1.13 (1.06–1.20) 1.08 (1.03–1
Triglycerides (mmol/l) 1.6 (1.3–1.9) 1.4 (1.2–1.6
GGT (IU) 33.3 (28.1–38.6) 24.4 (21.9–2
UACR (g/mol) 5.7 (2.4–9.0) 7.6 (2.3–12
Smokers (%) 54.7 (44.0–65.3) 51.8 (42.4–6
Drinkers (%) 52.3 (41.7–63.0) 60.7 (51.4–7
Risky drinkers (%) 30.2 (20.4–40.0) 29.9 (21.1–3
PA sufficient (%) 21.8 (13.1–30.6) 26.4 (18.0–3
Male n¼62 n¼8
Age (years) 37.5 (34.8–40.3) 35.1 (32.2–
WC (cm) 88.1 (84.5–91.7) 99.3 (95.2–
BMI (kg/m2) 23.1 (21.9 -24.3) 29.6 (27.9
SBP (mmHg) 123.0 (120.4–125.5) 126.1 (124.4
DBP (mmHg) 69.9 (67.7–72.0) 66.5 (64.5–
Fasting glucose (g/l) 5.4 (4.8–6.0) 5.9 (5.3–6
Cholesterol (mmol/l) 5.2 (5.0–5.5) 5.1 (4.9–5
HDLC (mmol/l) 1.16 (1.08–1.24) 1.08 (1.02–
Triglycerides (mmol/l) 2.4 (1.9–2.9) 1.9 (1.6–2
GGT (IU) 86.8 (66.4–107.2) 40.0 (33.6–
UACR (g/mol) 13.9 (5.7–22.2) 6.9 (2.4–1
Smokers (%) 71.0 (59.5–82.4) 63.3 (52.5–
Drinkers (%) 91.7 (84.6–98.8) 79.7 (70.8–
Risky drinkers (%) 73.3 (62.0–84.7) 48.1 (36.9–
PA sufficient (%) 21.0 (10.7–31.3) 41.3 (30.3–
Figures in the table are means or % (95% CI); P<0.05 with analysis of variance (ANOVA) or C
cholesterol; IU, international unit; PA, physical activity; UACR, urine albumin creatinine ratio; W
more than 2drinks/day for women [13]; PA sufficiently defined as having moderate to vigorous
706 www.jhypertension.comintake for fruits and vegetables, and 23% met the physical
activity guidelines, whereas 43% were self-reported ‘heavy’
drinkers. One hundred and fifty participants (37%) were
obese, 37 (9%) were diagnosed with diabetes and 80
(27.1%) had albuminuria. Compared with the aboriginal
participants, the TSIs had substantially higher BMI, lower
triglycerides and alcohol intake levels, especially in males.
Hundred hypertension cases developed in a total of 401
participants with 2633.4 person-years of follow-up. The
average follow-up period was 6.6 years (ranging from
4.5 to 9 years) among those completing the second survey.
Of those, 65 were males with an incidence rate of 60.5/1000
person-years compared to 22.6/1000 person-years in
females. The incident rate was 44.4/1000 in aboriginal
people compared to 37.3/1000 person-years in TSIs. The
overall incidence was 38.3/1000 person-years. The age-
standardized hypertension incidence rate in female indig-
enous participants was 29.8/1000 person-years, and was
74.7/1000 person-years in males, with the total incidence
ratio of 51.9/1000 person-years [95% confidence interval
(CI) 51.8–52.0]. Males were three times (95% CI 1.9–4.4)
more likely to develop hypertension than females. Inci-
dence increased with age. Compared with those aged less
than 35 years, those aged 35–54 years had a 2.4 times higher
risk of hypertension (95% CI 1.6–3.7), and those aged overp in rural indigenous communities in North Queensland
Joint descendents All groups
0 n¼38 N¼235
4.1) 31.1 (27.5–34.6) 32.4 (30.9–33.9)
04.6) 98.5 (92.4–104.5) 97.2 (94.9–99.5)
2.8) 30.3 (27.3–33.2) 29.1 (28.0–30.1)
119.80) 116.6 (113.6–119.6) 116.3 (114.9–117.7)
4.7) 64.2 (61.1–67.3) 63.5 (62.3–64.7)
) 5.1 (4.6–5.6) 5.2 (5.0–5.5)
) 4.3 (4.1–4.6) 4.6 (4.5–4.8)
.12) 1.09 (1.02–1.17) 1.10 (1.07–1.13)
) 1.1 (1.0–1.3) 1.4 (1.3–1.6)
7.0) 23.1 (17.7–28.6) 27.5 (25.0–30.0)
.9) 12.8 (-2.8–28.4) 8.6 (6.3–11.0)
1.2) 63.2 (47.5–78.8) 54.7 (48.3–61.1)
0.1) 66.7 (51.0–82.4) 58.5 (52.1–64.9)
8.7) 44.4 (27.9–61.0) 32.3 (26.2–38.4)
4.7) 15.8 (4.0–27.6) 23.0 (17.6–28.4)
3 n¼24 N¼169
38.0) 32.4 (27.4–37.3) 35.6 (33.8–37.5)
103.5) 100.7 (93.3–108.2) 95.3 (92.6–98.0)
-31.3) 29.2 (26.2–31.3) 27.1 (26.0–28.2)
–127.7) 124.2 (121.1–127.2) 124.6 (123.3–125.9)
68.5) 66.9 (63.8–70.0) 67.8 (66.5–69.2)
.4) 5.3 (4.2–6.3) 5.6 (5.2–6.0)
.4) 4.7 (4.3–5.0) 5.1 (4.9–5.3)
1.14) 1.13 (1.03–1.24) 1.11 (1.07–1.16)
.2) 1.3 (1.0–1.6) 2.0 (1.7–2.2)
46.4) 33.8 (26.9–40.7) 56.0 (47.3–64.6)
1.4) 10.4 (-3.4–24.1) 8.1 (5.5–10.6)
74.1) 54.2 (33.7–74.7) 64.8 (57.5–72.2)
88.7) 95.8 (87.6–104.0) 86.5 (81.2–91.8)
59.3) 50.0 (29.4–70.6) 57.7 (50.1–65.3)
52.2) 41.7 (21.4–62.0) 33.7 (26.5–41.0)
hi-square tests. GGT, gamma-glutamyl transferase; HDLC, high-density lipoprotein
C, waist circumference. Risk drinker defined as those more than 4drinks/day for men and
physical activity for more than 30min/day for 5 days in the week before the survey [14].
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5.8). Aboriginal adults were twice as likely as TSIs to
develop hypertension (adjusted hazard ratio 1.9, 95% CI
1.2–3.0) (Table 2).
Obesity defined either by BMI or waist circumference
strongly associated with hypertension incidence regardless
of age and sex (hazard ratio ranging between 2.5 and 2.9).
Albuminuria increased the risk of hypertension by 70%
(hazard ratio 1.7, 95% CI 1.1–2.8) after adjusted for age,
sex, ethnicity and BMI. Blood glucose, lipids and behav-
ioural factors such as smoking and drinking, and physical
activity did not appear to predict hypertension incidence.
Among the aboriginal subgroup, the hazard ratio for at-risk
drinkers (>4 drinks/day for males and >2 drinks/day
for females) was 2.2 (95% CI 1.03–4.8) and attenuated
to null when adjusted for sex. Higher baseline GGT
levels increased the risk by 90% (hazard ratio 1.9, 95% CI
1.01–3.5), independent of age, sex and BMI, and drinking
(Table 3).
DISCUSSION
In this cohort of indigenous Australians living in rural and
remote communities in North Queensland, we found the
standardized hypertension incidence of 51.9 per 1000 per-
son-years with 29.8 in females and 74.7 per 1000 person-
years in males. The incidence was approximately twice
among a national representative population longitudinal
study [The Australian Diabetes (AusDiab) study], which
found a 3% annual incidence rate of hypertension using
similar methodology and over the same time period [19].
Our findings are similar to those reported in several follow-
up studies looking at ethnic differences for African Amer-
icans, Hispanics and Asians, which found that incidence
varied with age, sex, ethnicity, and year of reporting and the
definition of hypertension [4,20]. These make detailedTABLE 2. Hypertension incidence by age, sex and ethnicity among 40
years)












15–24 0/174.9 (25) 0 1/194.6 (29) 5.1 (
25–34 5/ 183.0 (26) 27.3 (11.4–65.7) 7/303.0 (46) 23.1 (
35–44 7/144.1 (20) 48.6 (23.2–101.9 4/165.5 (24) 24.2
45–54 1/71.4 (9) 14.0 (2.0–99.4) 2/45.7 (8) 43.8 (1
55–64 1/37.6 (5) 26.6 (3.7–188.8) 0/9.0 (1)
>¼65 1/11.8 (2) 84.7 (11.9–601.2) 2/13.6 (2) 147.1 (
Subtotal 15/622.7 (87) 24.1 (14.5–40.0) 16/731.4 (110) 21.9 (
Male
15–24 2/54.9 (8) 36.5 (9.1–145.8) 8/158.3 (21) 50.5 (2
25–34 6/115.2 (17) 52.1 (23.4–115.9) 4/138.2 (21) 28.9 (1
35–44 14/144.4 (22) 97.0 (57.4–163.7) 5/99.0 (16) 50.5 (2
45–54 5/73.2 (11) 68.3 (28.4–164.2) 8/89.8 (14) 89.1 (4
55–64 4/30.1 (4) 132.7 (49.8–353.6) 5/38.9 (7) 128.6 (5
65 No observation 1/4.6 (1) 217.3 (3
Subtotal 31/417.7 (62) 74.2 (52.2–105.5) 31/528.8 (80) 58.6 (4
Total 46/1040.5 (149) 44.4 (33.1–59.0) 47/1260.2 (193) 37.3 (2
CI, confidence interval; TSIs, Torres Strait Islanders. N, total number of observations of three eth
ethnicity.
Journal of Hypertensioncomparisons difficult. Fewer studies were conducted
among ‘aboriginal people’ in other areas of the world,
except for the Strong Heart Study, among 4549 American
Indians with a 4-year follow-up period [21]. The study
shows hypertension incidence increases with age, but does
not differ by sex, and is associated with obesity and albu-
minuria, which is similar to our study [21].
In line with other longitudinal studies among European
[22], American [23,24] and Asian [25] populations, we also
found that baseline obesity increased the risk of incident
hypertension, defined either by BMI and waist circumfer-
ence. BMI was found to predict the risk of hypertension in a
review paper including 15 prospective cohort studies
among various populations, although different other factors
are added in the risk models in these studies [26]. We found
that BMI and waist circumference as measures of obesity
were equally predictive of incident hypertension. This is
consistent with a recent meta-analysis looking at data from
various ethnic groups to evaluate the cross-sectional associ-
ation between several anthropometric measurements and
hypertension [27]. Obesity-related hypertension appears to
involve multiple and linked pathways including insulin
resistance, inappropriate sympathetic and renal angiotensin
system activation, and inflammatory responses leading to
endothelial dysfunction, atheroma and arterial wall stiff-
ness. dipeptidyl peptide-4-mediated incretin signalling can
affect vascular function, immune responses and natriuresis
in obesity states. Oestrogen-mediated insulin sensitivity in
premenopausal women who do not have obesity is com-
promised when they develop obesity. An alteration in the
gut microbiome in obesity is another factor that contributes
to insulin resistance and dysfunctional immunity [28].
We also found that albuminuria predicts incident hyper-
tension in this cohort of Australian indigenous adults inde-
pendent of age, sex and BMI. This is consistent with other










0.7–36.5) 0/46.3 (9) 0 2.4 (0.3–17.1)
11.0–48.5) 0/74.4 (14) 0 21.4 (12.2–37.7)
(9.1–64.4) 2/57.7 (11) 34.6 (8.7–138.4) 35.4 (20.5–60.9)
0.9–175.0) 2/18.4 (4) 108.4 (27.1–433.5) 36.9 (15.4–88.6)
0 No observation 21.5 (3.0–152.3)
36.8–588.0) No observation 118.1 (38.1–366.0)
13.4–35.7) 4/196.9 (38) 20.3 (7.6–54.1) 22.6 (16.2–31.4)
5.3–101.0) 1/42.9 (8) 23.3 (3.3–165.4) 42.9 (23.8–77.5)
0.9–77.1) 1/45.2 (7) 22.1 (3.1–157.0) 36.8 (20.4–66.5)
1.0–121.3) 1/30.5 (6) 32.9 (4.6–233.4) 73.0 (47/1–113.2)
4.6–178.2) 0/5.9 (1) 0 77.0 (44.7–132.5)
3.5–309.1) 0/11.4 (2) 0 111.9 (58.2–215.0)
0.6–1452.3) No observation 217.3 (30.6–1542.3)
1.2–83.4) 3/135.9 (24) 22.1 (7.1–68.4) 60.0 (47.1–76.6)
8.0–49.6) 7/332.8 (62) 21.0 (10.0–44.1) 38.0 (31.2–46.2)
nicity backgrounds; no., number of observations in each age group from the designated
www.jhypertension.com 707
TABLE 3. Hazard ratio (95% confidence interval) of risk factors of hypertension incidence by ethnicity among 401 indigenous participants
in North Queensland
Aboriginal (N¼149) TSIs (N¼193) Overall (N¼401)
Crude HR Adjusted HRa Crude HR Adjusted HRa Crude HR Adjusted HRa
Abdominal obesity Reference¼<88 cm in women and¼<102 in men
Yes 0.9 (0.5–1.7) 2.0 (0.9–4.2) 1.1 (0.6–2.0) 2.4 (1.2–4.6) 1.1 (0.7–1.6) 2.5 (1.5–3.9)
BMI category Reference category, BMI <25
25–29.9 1.3 (0.7–2.7) 1.3 (0.6–2.7) 0.7 (0.3–1.8) 0.8 (0.3–2.1) 0.9 (0.5–1.6) 0.9 (0.5–1.6)
30 1.3 (0.6–2.7) 2.5 (1.03–6.2) 1.7 (0.9–3.5) 2.9 ((1.4–6.2) 1.5 (1.0–2.3) 2.9 (1.9–4.8)
Albuminuria Reference category, UACR <2.5 for males and <3.5 for females
Yes 1.1 (0.5–2.2) 1.0 (0.5–1.7) 3.5 (1.8–6.7) 2.4 (1.2–4.9) 2.1 (1.4–3.4) 1.7 (1.1–2.8)
GGT categories Reference category, GGT<50
50 2.8 (1.5–5.0) 1.9 (1.01–3.5) 1.6 (0.7–3.7) 1.1 (0.5–2.5) 2.2 (1.4–3.4) 1.4 (0.9–2.2)
Diabetes Reference category, No
Yes 1.0 (0.3–2.7) 0.5 (0.2–1.5) 2.6 (1.2–5.4) 2.1 (0.9–4.7) 2.1 (1.2–3.6) 1.6 (0.9–2.9)
Glucose categories Reference category, glucose<4.5
4.5–5.5 1.2 (0.6–2.4) 1.0 (0.5–2.1) 0.9 (0.4–2.0) 0.7 (0.4–1.6) 0.9 (0.6–1.5) 0.8 (0.5–1.3)
5.6 1.6 (0.7–3.5) 0.9 (0.4–2.0) 2.0 (0.9–4.6) 1.4 (0.6–3.4) 1.9 (1.1–3.1) 1.3 (0.8–2.4)
Dyslipidaemia Reference category, No
Yes 1.3 (0.7–2.3) 1.0 (0.6–1.9) 1.0 (0.5–1.7) 0.9 (0.5–1.7) 1.1 (0.8–1.7) 1.1 (0.7–1.6)
Smoking status Reference category, No
Yes 1.6 (0.9–2.9) 1.3 (0.7–2.3) 1.0 (0.5–1.8) 0.8 (0.4–1.4) 0.9 (0.6–1.3) 0.7 (0.5–1.1)
Alcohol drinking Reference category, No
Moderate 1.8 (0.7–4.4) 1.8 (0.7–4.5) 0.7 (0.3–1.5) 0.5 (0.2–1.1) 0.9 (0.5–1.6) 0.6 (0.3–1.2)
Risky 2.2 (1.03–4.8) 1.4 (0.6–3.2) 0.8 (0.4–1.5) 0.5 (0.2–1.1) 0.9 (0.6–1.5) 0.6 (0.4–1.0)
PA sufficient Reference category, No
Yes 0.7 (0.3–1.5) 1.0 (0.4–2.0) 1.2 (0.7–2.2) 1.1 (0.6–2.1) 0.9 (0.6–1.4) 0.9 (0.6–1.5)
HR, hazard ratio; TSIs, Torres Strait Islanders.
aAdjusted for age and sex in each ethnicity subgroup and overall adjusted further for ethnicity; Abdominal obese, and PA sufficient defined by WHO criteria [14]; diabetes defined using
WHO criteria [17]; dyslipidaemia defined by National Heart Foundation criteria [18].
Li and McDermottethnic subgroups [32]. Albuminuria is an early marker of
endothelial dysfunction and it predicts renal disease pro-
gression, cardiovascular and all-cause mortality [33,34]. The
mechanisms underlying the link include increased intra-
vascular volume, endothelin secretion, renin–angiotensin
and sympathetic nervous system activation, and decreased
nitric oxide production and endothelial function [35].
Indeed, the kidney has been proposed as a ‘window’ for
early systemic CVD where glomerular albumin leakage
signals widespread the disease [36]. Australian indigenous
people have higher rates of albuminuria, but lower
estimated glomerular filtration rate (eGFR) than the
general population, and this may account for much of
the excess CVD risk in this group [37]. We also found that
increased GGT significantly predicted incident hyperten-
sion independent of age, sex, BMI and self-reported alco-
hol consumption. This is consistent with a recent meta-
analysis including 13 prospective cohort studies during
1991–2012 among males and females from Japan, Korea,
China, Turkey, France and USA [38]. Elevated GGT can
signal liver injury generally, and non-alcoholic fatty liver
disease associated with abdominal obesity and other fea-
tures of the metabolic syndrome [39]. Increased GGT
predicts incident hypertension and diabetes via pro-
inflammatory pathways and oxidative stress involving
increased fibrinogen, C-reactive protein and free radicals
[40,41].
Strengths of this study include a representative com-
munity-based sample of indigenous adults and objective
clinical measurements. Limitations include a relatively short
follow-up period, lack of detailed medical and family
history, and some potential confounding factors, and a708 www.jhypertension.comrelatively small follow-up sample. The findings that obesity
and other markers of metabolic dysfunction were the
strongest predictors of incident hypertension, and that
indigenous Australians had excessive risk for both these
compared to the general population, were consistent with
reports from other ethnic groups in North America and
Europe. The challenge going forward is to find effective
obesity prevention and treatment measures at a population
level which is acceptable and feasible in low-income com-
munities.
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Reviewer 1
It is always interesting for epidemiologists to have data
about isolated, secluded, primitive or special popu-
lations. Although the Aboriginal people living in North-
ern Queensland described herein probably do not
represent a population in the epidemiological meaningof the term, the results add knowledge to the topic of
blood pressure trend and risk in particular subjects. We
studied in epidemiological setting African (Lancet 1996;
348: 784–788; Arterioscl Thromb Vasc Biol 1999: 19:
1250–1256) and South-American (J Hypertens 1999; 17:
749–756; J Hypertens 1997; 15: 1083–1090) primitive
people and this remarkable paper represents a new tile
in this difficult puzzle.www.jhypertension.com 709
Li and McDermottReviewer 2
The strength of this study relates to the information about
the incidence of hypertension in a so far less well studied
population. As reported, the incidence of hypertension in
this Aboriginal Australian population is about twice that of
the general Australian population and is among the highest
world wide. The risk factors for the development of hyper-
tension are interesting, in particular the importance of
gamma-glutamyl transferase as a marker for inflammation,710 www.jhypertension.comwhich is a strong predictor for hypertension in this popu-
lation. Another interesting finding in this study is the great
difference in the incidence of hypertension between
women and men, 22.6 versus 60.0 per 1000 patient years,
respectively. The weakness of the study is, as the authors
described, the small follow-up sample, but, as the authors
mentioned, apart from age, there were no significant differ-
ences between the follow-up and the lost to follow-up
group of individuals.Volume 33  Number 4  April 2015
